Strategic Partnerships DiaSorin’s growing ecosystem includes recent collaborations with McKesson, Thermo Fisher Scientific, and QIAGEN, presenting cross-selling opportunities across distribution channels, hospital networks, and companion diagnostic programs.

Point-of-Care Expansion The Liaison NES rapid molecular system with 15-minute panels has exclusive hospital-channel distribution in the US and CLIA waiver, signaling strong potential to upsell to acute care and ER departments seeking fast infectious disease triage.

Automated Workflows Partnerships in laboratory automation and track-based solutions (Inpeco collaboration) create opportunities to offer integrated, end-to-end workflows that reduce manual steps and increase testing throughput for high-volume labs.

Comprehensive Panels With VERIGENE syndromic panels and a broad Simplexa catalog plus LIAISON assays, there is potential to package multi-test bundles for hospitals and laboratories aiming to consolidate vendors and streamline testing menus.

Precision Medicine Focus Leadership additions in precision medicine and companion diagnostics combined with global immunodiagnostics capabilities point to cross-sell opportunities into oncology, transplant, and infectious disease programs that require targeted molecular assays.